Issues concerning the estimation of the TD50.
暂无分享,去创建一个
D G Hoel | C J Portier | C. Portier | D. Hoel
[1] Stephen W. Lagakos,et al. On the Representativeness Assumption in Prevalence Tests of Carcinogenicity , 1985 .
[2] Barbara McKnight,et al. Tests for differences in tumor incidence based on animal carcinogenesis experiments , 1984 .
[3] C. Portier. Estimating the tumour onset distribution in animal carcinogenesis experiments , 1986 .
[4] Malcolm C. Pike,et al. The TD50: a proposed general convention for the numerical description of the carcinogenic potency of chemicals in chronic-exposure animal experiments. , 1984 .
[5] C. Portier,et al. Optimal design of the chronic animal bioassay. , 1983, Journal of toxicology and environmental health.
[6] C. Portier,et al. Low-dose-rate extrapolation using the multistage model. , 1983, Biometrics.
[7] D G Hoel,et al. Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program's carcinogenicity experiments. , 1986, Cancer research.
[8] Thomas L. Vincent,et al. Pest Management Programs via Optimal Control Theory , 1975 .
[9] M. Pike,et al. Calculation of carcinogenic potency from long-term animal carcinogenesis experiments. , 1984, Biometrics.
[10] R L Sielken,et al. Estimation of "safe doses" in carcinogenic experiments. , 1977, Journal of environmental pathology and toxicology.
[11] J D Kalbfleisch,et al. Nonparametric methods for survival/sacrifice experiments. , 1986, Biometrics.
[12] M. Pike,et al. A carcinogenic potency database of the standardized results of animal bioassays , 1984, Environmental health perspectives.